CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $9,000 | -57.1% | 600 | -70.0% | 0.01% | -52.9% |
| Q3 2015 | $21,000 | +40.0% | 2,000 | +233.3% | 0.02% | +88.9% |
| Q4 2013 | $15,000 | -40.0% | 600 | -14.3% | 0.01% | -40.0% |
| Q3 2013 | $25,000 | -46.8% | 700 | -76.7% | 0.02% | -54.5% |
| Q2 2013 | $47,000 | – | 3,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |